BATCH #BATCH-8492 · HPLC 99.4%
Tissue Repair & Angiogenesis Matrix
Musculoskeletal Matrix
Synthesized BPC-157 (10mg) & TB-500 (10mg) Dual-Compound Protocol.
Select Research Tier
Dispatch Schedule
ISO-17025 Batch VerifiedLyophilized Stability
Dosing timeline — 8-Weeks
Per-compound administration schedule across 8 weeks.
WK 1 · 250 mcg each / day
WK 2 · 250 mcg each / day
WK 3 · 250 mcg each / day
WK 4 · 250 mcg each / day
WK 5 · 250 mcg each / day
WK 6 · 250 mcg each / day
WK 7 · 250 mcg each / EOD
WK 8 · 250 mcg each / EOD
12345678
Loading
WK 1–2
250 mcg each / day
Saturation of repair pathways
Repair
WK 3–6
250 mcg each / day
Peak angiogenesis window
Taper
WK 7–8
250 mcg each / EOD
Consolidation & wash-in
Kit composition
- 10 mg
BPC-157
Angiogenic signaling / tendon repair
- 10 mg
TB-500
Actin regulation / cell migration
- 2 × 3 mL
Bacteriostatic Water
Reconstitution diluent
- × 30
U-100 Syringes
Precision administration